期刊文献+

HPLC-PDA联合UPLC-Triple TOF MS法确证恩诺沙星注射液中的非法添加物 被引量:2

Identification of Illegal Additive in Enrofloxacin Injection by UPLC-Triple TOF MS and HPLC-PDA Method
下载PDF
导出
摘要 为确证1批恩诺沙星注射液中的非法添加物,通过HPLC-PDA法初筛,利用高分辨质谱对未知物进行筛查,并用HPLC-PDA和UPLC-Triple TOF MS两种方法进行验证,结果显示,该批样品中的非法添加物为加替沙星。本研究为兽药中非法添加物筛查及定性确证提供了一个有效的思路与方法。 To confirm the illegal addition in one batch of enrofloxacin injection.The unknown substance was screened by HPLC-PDA high-resolution mass spectrometry,and confirmed by combined HPLC-PDA and UPLC-Triple TOF MS,The results showed that the illegal additive in this batch of enrofloxacin injection was gatifloxacin.This study provides an effective ideas and method for the illegal additives qualitative analysis in veterinary drugs.
作者 宋慧敏 熊玥 汪云花 孙瑶 石慧慧 SONG Hui-min;XIONG Yue;WANG Yun-hua;SUN Yao;SHI Hui-hui(Jiangsu Testing Institute of Veterinary Drug and Feed,Nanjing 210036,China)
出处 《中国兽药杂志》 2021年第8期54-59,共6页 Chinese Journal of Veterinary Drug
关键词 恩诺沙星注射液 非法添加 加替沙星 确证 enrofloxacin injection illegal addition gatifloxacin identification
  • 相关文献

参考文献3

二级参考文献41

  • 1赵树清,王金生.新型氟喹诺酮抗菌剂——AM—1155[J].中国医药情报,1996,2(4):249-252. 被引量:4
  • 2曾正渝.苯甲酸及其钠盐在食品和药品中的应用[J].中国药业,2007,16(6):64-64. 被引量:30
  • 3GB2760-2011食品添加剂使用卫生标准[S].2011.
  • 4JLM. Oral and iv formulations of gatifoxacin cleared for US. market. Am J Health-Syst Pharm, 2000; 57:204
  • 5Hosaka M, Kinoshita S, Toyama A, et al. Antibacterial properties of AM-1155, a new 8-methoxy quinolone. J Antimicrob Chemther,1995; 36:293
  • 6Tomioka H, Saito H, Sato K. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin and ofloxacin. Antimicrob Agents Chemother, 1993;37:1259
  • 7Takei M, Fukuda H, Yasue T, et al. Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian typeⅡ topoisomerase. Antimicro Agents Chemother, 1998;42:2678
  • 8Wakabayshi E, Mitsuhashi S. In vitro antibacterial activitiy of AM-1155, a novel 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother, 1994;38:594
  • 9Fukuda H, Hori S, Hiramatsu K. Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone- resistants mutants and the norA transformant of staphylococcus aureus. Antimicrob Agents Chemother, 1998;42:1917
  • 10Deguchi T, Yasuda M, Nakano M, et al. Comparision of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC. Chemotherapy, 1997;43:239

共引文献78

同被引文献29

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部